← United States · Coverage record
US · SEC FORM 4
BELITE BIO, INC
BLTE · Nasdaq · CIK 0001889109 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
143 Form 4 transaction lines observed in the same window
141 sales · 2 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot.—
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 1,057,536
- Previous report
- 1,050,466
- Avg daily volume
- 145,206
- Days to cover
- 7.3
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
No qualifying code P equity purchase is present in the local Form 4 history.
Form 4 evidence
177 transaction lines in the latest 365-day window; 177 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Scholl Hendrik Peter | Sale (S) | American depositary share | 500 | USD 165.32 | USD 82,659 | SEC filing ↗ |
| 2026-09-08 | Lin Yu-Hsin | Sale (S) | American depositary share | 26,000 | USD 196.56 | USD 5,110,495 | SEC filing ↗ |
| 2026-09-08 | Chuang Hao-Yuan | Sale (S) | American depositary share | 17,962 | USD 196.42 | USD 3,528,140 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Scholl Hendrik Peter | Sale (S) | American depositary share | 500 | USD 165.32 | USD 82,659 | SEC filing ↗ |
| 2026-09-08 | Lin Yu-Hsin | Sale (S) | American depositary share | 26,000 | USD 196.56 | USD 5,110,495 | SEC filing ↗ |
| 2026-09-08 | Chuang Hao-Yuan | Sale (S) | American depositary share | 17,962 | USD 196.42 | USD 3,528,140 | SEC filing ↗ |
| 2026-09-04 | Lin Yu-Hsin | Sale (S) | American depositary share | 74,435 | USD 187.71 | USD 13,972,033 | SEC filing ↗ |
| 2026-09-04 | Chuang Hao-Yuan | Sale (S) | American depositary share | 49,433 | USD 187.63 | USD 9,275,352 | SEC filing ↗ |
| 2026-08-12 | Lin Yu-Hsin | Sale (S) | American depositary share | 365 | USD 180.35 | USD 65,827 | SEC filing ↗ |
| 2026-08-12 | Chuang Hao-Yuan | Sale (S) | American depositary share | 367 | USD 180.35 | USD 66,187 | SEC filing ↗ |
| 2026-06-18 | Scholl Hendrik Peter | Sale (S) | American depositary share | 10,000 | USD 145.24 | USD 1,452,400 | SEC filing ↗ |
| 2026-06-16 | Scholl Hendrik Peter | Sale (S) | American depositary share | 10,000 | USD 140.57 | USD 1,405,730 | SEC filing ↗ |
| 2026-05-07 | MATA NATHAN L. | Sale (S) | American depositary share | 666 | USD 153.21 | USD 102,038 | SEC filing ↗ |
| 2026-05-06 | MATA NATHAN L. | Sale (S) | American depositary share | 1,000 | USD 153.84 | USD 153,838 | SEC filing ↗ |
| 2026-05-05 | MATA NATHAN L. | Sale (S) | American depositary share | 1,000 | USD 155.50 | USD 155,502 | SEC filing ↗ |
| 2026-05-04 | MATA NATHAN L. | Sale (S) | American depositary share | 1,000 | USD 155.64 | USD 155,638 | SEC filing ↗ |
| 2026-05-01 | MATA NATHAN L. | Sale (S) | American depositary share | 1,000 | USD 155.78 | USD 155,779 | SEC filing ↗ |
| 2026-04-30 | MATA NATHAN L. | Sale (S) | American depositary share | 1,000 | USD 156.97 | USD 156,975 | SEC filing ↗ |
| 2026-04-29 | MATA NATHAN L. | Sale (S) | American depositary share | 1,000 | USD 155.82 | USD 155,817 | SEC filing ↗ |
| 2026-04-28 | MATA NATHAN L. | Sale (S) | American depositary share | 1,000 | USD 159.16 | USD 159,162 | SEC filing ↗ |
| 2026-04-27 | MATA NATHAN L. | Sale (S) | American depositary share | 1,000 | USD 162.64 | USD 162,642 | SEC filing ↗ |
| 2026-04-24 | MATA NATHAN L. | Sale (S) | American depositary share | 1,000 | USD 159.56 | USD 159,556 | SEC filing ↗ |
| 2026-04-23 | MATA NATHAN L. | Sale (S) | American depositary share | 1,000 | USD 166.28 | USD 166,282 | SEC filing ↗ |
| 2026-04-22 | MATA NATHAN L. | Sale (S) | American depositary share | 1,000 | USD 170.39 | USD 170,385 | SEC filing ↗ |
| 2026-04-21 | Lin Yu-Hsin | J (J) | Ordinary Share | 10,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-21 | Chuang Hao-Yuan | J (J) | Ordinary Share | 10,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-21 | MATA NATHAN L. | Sale (S) | American depositary share | 1,000 | USD 166.00 | USD 166,000 | SEC filing ↗ |
| 2026-04-20 | MATA NATHAN L. | Sale (S) | American depositary share | 1,000 | USD 163.60 | USD 163,596 | SEC filing ↗ |
| 2026-04-17 | MATA NATHAN L. | Sale (S) | American depositary share | 1,000 | USD 161.63 | USD 161,631 | SEC filing ↗ |
| 2026-04-16 | MATA NATHAN L. | Sale (S) | American depositary share | 1,000 | USD 160.38 | USD 160,380 | SEC filing ↗ |
| 2026-04-15 | MATA NATHAN L. | Sale (S) | American depositary share | 1,000 | USD 168.30 | USD 168,296 | SEC filing ↗ |
| 2026-04-09 | Lin Yu-Hsin | Sale (S) | American depositary share | 9,200 | USD 181.45 | USD 1,669,355 | SEC filing ↗ |
| 2026-04-09 | Chuang Hao-Yuan | Sale (S) | American depositary share | 6,200 | USD 181.50 | USD 1,125,322 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | BLTE |
| CIK | 0001889109 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 177 transaction lines from 2026-04-09 to 2026-10-01 0 P purchase lines · 175 S sale lines · 2 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.